ATE301664T1 - Boronsäurehaltige reagenzien und oligonukleotide - Google Patents

Boronsäurehaltige reagenzien und oligonukleotide

Info

Publication number
ATE301664T1
ATE301664T1 AT00916555T AT00916555T ATE301664T1 AT E301664 T1 ATE301664 T1 AT E301664T1 AT 00916555 T AT00916555 T AT 00916555T AT 00916555 T AT00916555 T AT 00916555T AT E301664 T1 ATE301664 T1 AT E301664T1
Authority
AT
Austria
Prior art keywords
reagents
boronic acid
oligonucleotides containing
containing boronic
polynucleotides
Prior art date
Application number
AT00916555T
Other languages
English (en)
Inventor
Robert J Kaiser
Mark L Stolowitz
Original Assignee
Agilent Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/272,978 external-priority patent/US6031117A/en
Priority claimed from US09/272,834 external-priority patent/US6013783A/en
Application filed by Agilent Technologies Inc filed Critical Agilent Technologies Inc
Application granted granted Critical
Publication of ATE301664T1 publication Critical patent/ATE301664T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6596Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having atoms other than oxygen, sulfur, selenium, tellurium, nitrogen or phosphorus as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/318Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/33Chemical structure of the base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Saccharide Compounds (AREA)
AT00916555T 1999-03-19 2000-03-17 Boronsäurehaltige reagenzien und oligonukleotide ATE301664T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/272,978 US6031117A (en) 1999-03-19 1999-03-19 Boronic acid containing phosphoramidite reagents
US09/272,834 US6013783A (en) 1999-03-19 1999-03-19 Boronic acid containing oligonucleotides and polynucleotides
PCT/US2000/007370 WO2000056740A1 (en) 1999-03-19 2000-03-17 Boronic acid containing reagents and oligonucleotides

Publications (1)

Publication Number Publication Date
ATE301664T1 true ATE301664T1 (de) 2005-08-15

Family

ID=26955773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00916555T ATE301664T1 (de) 1999-03-19 2000-03-17 Boronsäurehaltige reagenzien und oligonukleotide

Country Status (11)

Country Link
EP (1) EP1165569B1 (de)
JP (1) JP3917372B2 (de)
KR (1) KR100541842B1 (de)
CN (1) CN1354752A (de)
AT (1) ATE301664T1 (de)
AU (1) AU778741B2 (de)
CA (1) CA2368101A1 (de)
DE (1) DE60021862D1 (de)
EA (1) EA200100987A1 (de)
MX (1) MXPA01009390A (de)
WO (1) WO2000056740A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10017763B2 (en) 2010-09-03 2018-07-10 Sarepta Therapeutics, Inc. dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
HK1201514A1 (en) 2011-11-18 2015-09-04 Sarepta Therapeutics, Inc. Functionally-modified oligonucleotides and subunits thereof
US9234048B2 (en) 2012-01-18 2016-01-12 Wisconsin Alumni Research Foundation Boronate-mediated delivery of molecules into cells
US9732101B2 (en) 2012-01-18 2017-08-15 Wisconsin Alumni Research Foundation Bioreversible boronates for delivery of molecules into cells
CN104411831B (zh) 2012-03-20 2020-08-11 萨勒普塔医疗公司 寡核苷酸类似物的硼酸缀合物
US11020417B2 (en) 2015-06-04 2021-06-01 Sarepta Therapeutics, Inc Methods and compounds for treatment of lymphocyte-related diseases and conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831046A (en) * 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
US6031117A (en) * 1999-03-19 2000-02-29 Prolinx Incorporated Boronic acid containing phosphoramidite reagents
US6013783A (en) * 1999-03-19 2000-01-11 Prolinx Incorporated Boronic acid containing oligonucleotides and polynucleotides

Also Published As

Publication number Publication date
EP1165569A1 (de) 2002-01-02
AU3764500A (en) 2000-10-09
CN1354752A (zh) 2002-06-19
MXPA01009390A (es) 2003-06-06
EP1165569B1 (de) 2005-08-10
AU778741B2 (en) 2004-12-16
KR20020001786A (ko) 2002-01-09
EA200100987A1 (ru) 2002-04-25
CA2368101A1 (en) 2000-09-28
JP2002540113A (ja) 2002-11-26
WO2000056740A1 (en) 2000-09-28
KR100541842B1 (ko) 2006-01-16
JP3917372B2 (ja) 2007-05-23
DE60021862D1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
ATE373672T1 (de) Synthese von methoxynukleoside und enzymatische nukleisäure moleküle
DE69503129D1 (de) Pteridin-nukleotidderivate als fluoreszierende sonden
PT990047E (pt) Metodos e composicoes para a analise de acidos nucleicos por espectroscopia de massa.
DE60036277D1 (de) Testgerät zur durchführung von nukleinsäure-amplifikationsreaktionen
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
AU4941101A (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
CY1106991T1 (el) Αντιπολλαπλασιαστικη δραση ολιγονουκλεοτιδιων πλουσιων σε g και μεθοδος χρησιμοποιησης αυτων για την προσδεση σε νουκλεολινη
DE10001477B4 (de) Diskontinuierliches Polykondensationsverfahren und Rührscheibenreaktor hierfür
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
ATE298623T1 (de) Chemischer reaktor und verfahren zur katalytischen gasphasenreaktionen
DE59902306D1 (de) Reaktor zur kontinuierlichen durchführung von gas-flüssig-, flüssig-flüssig- oder gas-flüssig-fest-reaktionen
DE69817066D1 (de) Exothermo Reaktionen und Verfahren dazu
DE69822473D1 (de) Lipid-polyamid-konjugate und zusammensetzungen zur verabreichung von nucleinsäuremolekülen
DE69928667D1 (de) Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen
DE69609725D1 (de) Neue polymerträger zur nukleinsäuresynthese
ATE263842T1 (de) Multiplex-sequenzierungsverfahren
DE59809244D1 (de) Reaktor für chemische Umsetzungen
DE60027045D1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
ATE301664T1 (de) Boronsäurehaltige reagenzien und oligonukleotide
ATE518963T1 (de) Evaneszenz-basierendes multiplex- sequenzierungsverfahren
DE59906395D1 (de) Vorrichtung zur durchführung von chemischen reaktionen
ATE357516T1 (de) Modulation molekularer wechselwirkungspositionen in rns und anderen biomolekülen
DE59814359D1 (de) Mikrostrukturierter biosensor, verwendung des biosensors und verfahren zur immobilisierung von biokatalysatoren
IL145826A0 (en) Quantitative assay for expression of genes in microarray
DE69817692D1 (de) Stabilisator für (Fluoroaryl)boran und Verfahren zur Stabilisierung und Kristallisierung von (Fluoroaryl)boran

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties